实用临床医药杂志2024,Vol.28Issue(1) :133-138.DOI:10.7619/jcmp.20233071

免疫细胞在直肠癌放化疗中预测价值的研究进展

Research progress on predictive value of immune cells in chemoradiotherapy for rectal cancer

陈虹 宝莹娜 赵建国
实用临床医药杂志2024,Vol.28Issue(1) :133-138.DOI:10.7619/jcmp.20233071

免疫细胞在直肠癌放化疗中预测价值的研究进展

Research progress on predictive value of immune cells in chemoradiotherapy for rectal cancer

陈虹 1宝莹娜 1赵建国1
扫码查看

作者信息

  • 1. 内蒙古医科大学附属医院,内蒙古呼和浩特,010050
  • 折叠

摘要

新辅助放化疗(NCRT)是局部晚期直肠癌(LARC)的标准治疗策略.患者对NCRT的反应性不同,故临床预后差异较大.建立敏感的生物标记物在NCRT前预测患者对治疗的反应性至关重要.肿瘤微环境(TME)中免疫细胞与LARC患者NCRT疗效密切相关.本文综述了细胞毒性T细胞、程序性细胞死亡-配体1(PD-L1)、肿瘤相关巨噬细胞(TAMs)、调节性T细胞(Treg)、中性粒细胞与淋巴细胞比值(NLR)与放化疗敏感性关系的研究进展,阐明了这些免疫细胞在预测直肠癌放化疗反应中的潜力及其各自的局限性,为今后研究提供可行方向.

Abstract

Neoadjuvant chemoradiotherapy(NCRT)is the standard therapeutic strategy for lo-cally advanced rectal cancer(LARC).Due to the different responses of patients to NCRT,the clini-cal prognosis of patients varies greatly.Therefore,it is important to establish sensitive biomarkers to predict the response of patients to treatments before NCRT.Immune cells in the tumor microenviron-ment(TME)were closely related to the efficacy of NCRT in patients with LARC.This paper re-viewed the research progress on the relationships of cytotoxic T cells,programmed death-ligand 1(PD-L1),tumor-associated macrophages(TAMs),regulatory T cells(Treg)and neutrophil to lym-phocyte ratio(NLR)with chemoradiotherapy sensitivity in rectal cancer,illustrated the potential and limitations of these immune cells in predicting chemoradiotherapy response in rectal cancer,and pro-vided a feasible direction for future researches.

关键词

直肠肿瘤/新辅助放化疗/免疫细胞/生物标记物/肿瘤微环境

Key words

rectal cancer/neoadjuvant chemoradiotherapy/immune cells/biomarkers/tumor microenvironment

引用本文复制引用

基金项目

内蒙古自治区科技计划项目(2019GG150)

出版年

2024
实用临床医药杂志
扬州大学,中国高校科技期刊研究会

实用临床医药杂志

CSTPCD
影响因子:1.543
ISSN:1672-2353
参考文献量47
段落导航相关论文